Recombinant Human Laforin/EPM2A Protein Summary
| Description |
Laforin/EPM2A (Human) GST-Tagged Recombinant Protein
Source: Wheat Germ (in vitro) Amino Acid Sequence: GNGPHHDRCCTYNENNLVDGVYCLPIGHWIEATGHTNEMKHTTDFYFNIAGHQAMHYSRILPNIWLGSCPRQVEHVTIKLKHELGITAVMNFQTEWDIV |
| Preparation Method |
in vitro wheat germ expression system
|
| Details of Functionality |
This protein is not active and should not be used for experiments requiring activity.
|
| Protein/Peptide Type |
Partial Recombinant Protein
|
| Gene |
EPM2A
|
Applications/Dilutions
| Application Notes |
Useful in Western Blot and ELISA. This protein has not been tested for any functionality. This product may contain endotoxins and is not suitable for use with live cells.
|
Reactivity Notes
Human
Packaging, Storage & Formulations
| Storage |
Store at -80C. Avoid freeze-thaw cycles.
|
| Buffer |
50 mM Tris-HCl, 10 mM reduced Glutathione, pH 8.0 in the elution buffer.
|
Notes
This product is produced by and distributed for Abnova, a company based in Taiwan.
Alternate Names for Recombinant Human Laforin/EPM2A Protein
- EC 3.1.3.16
- EC 3.1.3.48
- epilepsy, progressive myoclonus type 2, Lafora disease (laforin)
- epilepsy, progressive myoclonus type 2A, Lafora disease (laforin)
- EPM2
- EPM2A
- Lafora PTPase
- Laforin
- LAFPTPase
- LD
- LDE
- MELF
Background
EPM2A – epilepsy, progressive myoclonus type 2A, Lafora disease (laforin)
